De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Nyrada Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

James Bonnar

Algemeen directeur

AU$354.3k

Totale compensatie

Percentage CEO-salaris	85.7%
Dienstverband CEO	no data
Eigendom CEO	0.08%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	5.1yrs

Recente managementupdates

Shareholders Will Probably Not Have Any Issues With Nyrada Inc.'s (ASX:NYR) CEO Compensation

Nov 12

Recent updates

Shareholders Will Probably Not Have Any Issues With Nyrada Inc.'s (ASX:NYR) CEO Compensation

Nov 12

Companies Like Nyrada (ASX:NYR) Can Afford To Invest In Growth

Jan 10

We're Keeping An Eye On Nyrada's (ASX:NYR) Cash Burn Rate

Feb 23

Analyse CEO-vergoeding

Hoe is James Bonnar's beloning veranderd ten opzichte van Nyrada's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	AU$354k	AU$304k	-AU$1m
Mar 31 2024	n/a	n/a	-AU$3m
Dec 31 2023	n/a	n/a	-AU$5m
Sep 30 2023	n/a	n/a	-AU$6m
Jun 30 2023	AU$394k	AU$294k	-AU$8m
Mar 31 2023	n/a	n/a	-AU$6m
Dec 31 2022	n/a	n/a	-AU$4m
Sep 30 2022	n/a	n/a	-AU$4m
Jun 30 2022	AU$464k	AU$274k	-AU$4m
Mar 31 2022	n/a	n/a	-AU$4m
Dec 31 2021	n/a	n/a	-AU$4m
Sep 30 2021	n/a	n/a	-AU$4m
Jun 30 2021	AU$378k	AU$277k	-AU$4m
Mar 31 2021	n/a	n/a	-AU$5m
Dec 31 2020	n/a	n/a	-AU$6m
Sep 30 2020	n/a	n/a	-AU$6m
Jun 30 2020	AU$302k	AU$275k	-AU$6m
Mar 31 2020	n/a	n/a	-AU$5m
Dec 31 2019	n/a	n/a	-AU$4m
Sep 30 2019	n/a	n/a	-AU$4m
Jun 30 2019	AU$306k	AU$250k	-AU$4m

Compensatie versus markt: De totale vergoeding ($USD 244.50K ) James } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 313.13K ).

Compensatie versus inkomsten: De vergoeding van James is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

James Bonnar

no data

Tenure

AU$354,285

Compensatie

Mr. James Bonnar has been Chief Executive Officer of Nyrada Inc. Mr. Bonnar had been Vice-President of R&D at Nyrada Inc. since February 2018. He joined Nyrada in February 2018, bringing over 20 years of e...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
John Moore	Non-Executive Chairman	5.3yrs	AU$129.05k	0.93% A$ 147.2k
Christopher Cox	Non-Executive Director	4.9yrs	AU$54.60k	0.78% A$ 124.0k
Marcus Frampton	Independent Non-Executive Director	5.3yrs	AU$54.60k	0.65% A$ 102.5k
Ian Dixon	Non-Executive Director	4.1yrs	AU$167.97k	5.7% A$ 903.1k
Rudiger Weseloh	Independent Non-Executive Director	5.3yrs	AU$49.64k	0.20% A$ 31.9k
Gisela Mautner	Non-Executive Director	2.2yrs	AU$57.03k	geen gegevens
Gary Housley	Chairman of Scientific Advisory Board	no data	geen gegevens	0.77% A$ 122.8k
Junichi Nabekura	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
David Burke	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
Gilles Lambert	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
Jim Palmer	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens

5.1yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van NYR wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.1 jaar).

Nyrada Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Nyrada Inc., Annual General Meeting, Nov 12, 2024

Shareholders Will Probably Not Have Any Issues With Nyrada Inc.'s (ASX:NYR) CEO Compensation

Nyrada Inc., Annual General Meeting, Nov 20, 2023

Less than half of directors are independent

Nyrada Inc., Annual General Meeting, Nov 21, 2022

Nyrada Inc. Announces Board Changes

Recent updates

Nyrada Inc., Annual General Meeting, Nov 12, 2024

Full year 2024 earnings released: AU$0.008 loss per share (vs AU$0.05 loss in FY 2023)

New major risk - Share price stability

New major risk - Market cap size

Nyrada Inc. has filed a Follow-on Equity Offering in the amount of AUD 1.965 million.

First half 2024 earnings released: EPS: AU$0.001 (vs AU$0.017 loss in 1H 2023)

Shareholders Will Probably Not Have Any Issues With Nyrada Inc.'s (ASX:NYR) CEO Compensation

Full year 2023 earnings released: AU$0.05 loss per share (vs AU$0.025 loss in FY 2022)

New minor risk - Financial data availability

New major risk - Share price stability

First half 2023 earnings released: AU$0.017 loss per share (vs AU$0.018 loss in 1H 2022)

Nyrada Inc., Annual General Meeting, Nov 20, 2023

Nyrada Inc. Provides Update on the Progress of Its Brain Injury Program

Less than half of directors are independent

Nyrada Inc., Annual General Meeting, Nov 21, 2022

Nyrada Inc. Announces Efficacy Study Published in Journal of Lipid Research

Full year 2022 earnings released: AU$0.03 loss per share (vs AU$0.03 loss in FY 2021)

Nyrada Inc. Announces Board Changes

Nyrada Inc. Provides Cholesterol-Lowering Program Update

Nyrada Inc. Unveils Target of Its Brain Injury Program as TRPC Ion Channels & Provides Phase I Study Update

European Patent to be Granted for Cholesterol-Lowering Drug of Nyrada Inc

Less than half of directors are independent

Nyrada Inc. Announces Its Newest Brain Injury Drug Candidate

Nyrada Inc. Announces Its Newest Brain Injury Drug Candidate

Companies Like Nyrada (ASX:NYR) Can Afford To Invest In Growth

Nyrada Inc Provides an Update on the Progress of its Brain Injury Program

Nyrada Inc Announces Encouraging Efficacy Results from Its in Vivo Study of NYX-PCSK9i Called called APOE*3-Leiden.CETP

Nyrada Inc Announces New Potent Cholesterol-Lowering Candidates

Nyrada Inc. announced that it expects to receive AUD 11 million in funding

We're Keeping An Eye On Nyrada's (ASX:NYR) Cash Burn Rate

Nyrada Inc. Releases Update on the Company's Two Drug Development Programs

Nyrada Inc. Secures Collaboration with Walter Reed Army Institute of Research and UNSW

Nyrada Reports Further Results from Cholesterol Study

New 90-day high: AU$0.45

New 90-day high: AU$0.28

New 90-day high: AU$0.23

Full year earnings released - AU$0.095 loss per share

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur